Coronado Biosciences Reports Financial Results for the First Quarter Ended March 31, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today its financial results for the first quarter ended March 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news